Inventor · disambiguated record
Gary L. Schieven
Also filed as: SCHIEVEN GARY · SCHIEVEN GARY L
10 granted patents·4 pending applications·274 citations·filing 1993–2021
91Inventor score
Top patents by PatentIndex Score
14 records- 0197US7153856B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·38 cites·8 claims
- 0288US5565491AUse of phosphotyrosine phospatase inhibitors for controlling cellular proliferationBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Oct 15, 1996·56 cites·52 claims
- 0382US5693627AUse of phosphotyrosine phosphatase inhibitors for controlling cellular proliferationBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Dec 2, 1997·41 cites·52 claims
- 0477US5877210APhosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferationBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Mar 2, 1999·30 cites·26 claims
- 0576US5597707ATumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their useBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 28, 1997·41 cites·13 claims
- 0674US6235740B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted May 22, 2001·45 cites·41 claims
- 0767US5583242AUse of phosphotyrosine phosphatase inhibitors for controlling cellular proliferationBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Dec 10, 1996·16 cites·5 claims
- 0866US11883420B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2021·Granted Jan 30, 2024·0 cites·4 claims
- 0963US11110106B2Sting agonists for treating bladder cancer and solid tumorsVENENUM BIODESIGN LLC·Filed 2020·Granted Sep 7, 2021·0 cites·20 claims
- 1055US2023310409A1Treating rheumatoid arthritisBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1155US2023310408A1Tlr7 inhibitor in combination with prednisolone or hydroxychloroquine for treating cutaneous lupus erythematosusBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1251US5846998AUse of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferationBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Dec 8, 1998·7 cites·9 claims
- 1347US2004204576A1Polynucleotides encoding a novel human phosphatase, BMY_HPP13Filed 2003·Application pending·0 cites
- 1445US2004110710A1Methods of reducing ischemic injuryFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary L. Schieven files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →